Gsk Share Discussion Threads

[geckotheglorious] 05/3/2022 09:43

Igoe

Because she is "SO" worth it!

Overpromoted purely for beign a woman. Post split she is completely underqualified to run the Pharmaceuticals side.

Still, she'll hoover up as much moolah until the inevitable.Nice little earner.

[igoe104] 05/3/2022 08:17

GSK are giving EW a 17% payrise, taking her total salary upto 8.2 million a year.🙄

[essentialinvestor] 04/3/2022 13:47

Michael, that valuation perhaps now looks on the high side?.

Multiples coming down quickly.

[tradermichael] 04/3/2022 13:41

GSK Mkt Cap: £75.4 bn

Haleon lowest f/c Value: £45bn

New GSK Mkt Cap ....... ??

[jonjoneil] 04/3/2022 12:25

And there goes Ukraine.
Don't care about Glaxo while all this is going on. I would willingly swap all my shares for a bullet in the madman's head.

[spoole5] 04/3/2022 09:29

There goes 1500. Stupidest takeover rejection ever.

[tradermichael] 03/3/2022 11:02

Contrarian!

[spoole5] 03/3/2022 08:34

And another one! Emma back selling lipstick yet?!

[spoole5] 02/3/2022 08:38

Market up GSK down. Another standard day at the gsk office!

[zho] 02/3/2022 07:07

Does Haleon herald halcyon days for investors?

GlaxoSmithKline could have safely shelved its long-planned big presentation to the City of its Panadol-to-Sensodyne consumer products division: most of the main financial details were aired in January in response to Unilever’s brief but entertaining £50bn takeover offer for the unit....

[charlie9038] 01/3/2022 22:07

Tweet

We’re making a £3m donation to the Red Cross’s Ukraine Crisis work to fund food, water, first aid, medicines, warm clothes and shelter. Ukrainian people have shown so much courage and bravery and we hope that a peaceful resolution can be reached as quickly as possible.

[jonjoneil] 01/3/2022 18:56

No, but I did have one begging me to buy theirs.

[ben guernsey] 01/3/2022 18:36

Any other shareholders received cold caller at home looking to acquire your GSK shares?

[tradermichael] 01/3/2022 11:22

Agree ..... ;0)

[alphorn] 01/3/2022 11:16

Looks clear to me - "EMA file acceptance is the first major regulatory milestone...."

I.e no marketing authorisation at this point.

[tradermichael] 01/3/2022 10:40

Yes, Aphorn, there is some confusion.

Here is the actual GSK Press release which I have just found:

[alphorn] 01/3/2022 10:03

TM - apologies, but your post doesn't make sense. .........received marketing authorisation...........application accepted for review.

It looks like the latter.

[jonjoneil] 01/3/2022 09:26

I tried to watch the webcast, but I kept falling asleep. Why did they spend four and a half hours on the presentation when one and a half would have been more than enough.
All that "super excited" rhetoric just doesn't cut it for me. Or the Market!

[spoole5] 01/3/2022 09:11

Market clearly not impressed with the presentation

[tradermichael] 01/3/2022 08:55

GlaxoSmithKline PLC said Tuesday that its drug Daprodustat has received marketing authorization by the European Medicines Agency.

The company said its application was accepted for review by the EMA.

The drug Daprodustat, aimed at treating anaemia of chronic kidney disease, is currently approved in Japan, the FTSE 100-listed company said.

[netcurtains] 01/3/2022 08:22

Its higher

[spoole5] 01/3/2022 08:17

Even good news can't shift this higher!

[jonjoneil] 28/2/2022 16:41

TM
just as you forecast a couple of days ago. The market loved today's presentation and we are heading back to 1600+p.

[jonjoneil] 28/2/2022 13:35

sales growth targets will not include any impact from Unilever when(and if)their competing brands come on stream.